Evidence map›Paper›PMID 28585545›Full record

ArticleNature communications2017

Sox5 regulates beta-cell phenotype and is reduced in type 2 diabetes.

A S Axelsson, T Mahdi, H A Nenonen, T Singh, S Hänzelmann, A Wendt, A Bagge, T M Reinbothe, J Millstein, X Yang and 19 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Influence of rsHealth science reports · 2025
    Article
  6. Article
  7. Article
  8. Stem Cell-Derived Islets for Type 2 Diabetes.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Genotype-Based Recall Studies in Complex Cardiometabolic Traits.Circulation. Genomic and precision medicine · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Diabetes: Why β cells fail in T2DM.Nature reviews. Endocrinology · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 8 institutions in 7 countries.

A S AxelssonLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
T MahdiLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
H A NenonenLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
T SinghLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
S HänzelmannInstitute of Biomedical Engineering, RWTH Aachen University Hospital, Pauwelstr 19, 52074 Aachen, Germany.
A WendtLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
A BaggeLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.ORCID 0000-0002-3897-9512
T M ReinbotheLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
J MillsteinSage Bionetworks, 1100 Fairview Avenue N, Seattle, Washington 98109, USA.
X YangSage Bionetworks, 1100 Fairview Avenue N, Seattle, Washington 98109, USA.
B ZhangSage Bionetworks, 1100 Fairview Avenue N, Seattle, Washington 98109, USA.
E G GusmaoInstitute of Biomedical Engineering, RWTH Aachen University Hospital, Pauwelstr 19, 52074 Aachen, Germany.
L ShuDepartment of Integrative Biology and Physiology, University of California, Los Angeles, 610 Charles E. Young Dr East, Los Angeles, California 90095, USA.
M SzabatDiabetes Research Group, Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, 5358-2350 Health Sciences Mall, Vancouver, British Columbia, Canada V6T 1Z3.
Y TangLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
J WangLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
S SalöLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
L EliassonLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
I ArtnerLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.ORCID 0000-0002-2895-5664
M FexLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
J D JohnsonDiabetes Research Group, Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, 5358-2350 Health Sciences Mall, Vancouver, British Columbia, Canada V6T 1Z3.
C B WollheimLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
J M J DerrySage Bionetworks, 1100 Fairview Avenue N, Seattle, Washington 98109, USA.
B MechamTrialomics, 6310 12th Avenue NE, Seattle, Washington 98115, USA.
P SpégelLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
H MulderLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
I G CostaInstitute of Biomedical Engineering, RWTH Aachen University Hospital, Pauwelstr 19, 52074 Aachen, Germany.
E ZhangLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
A H RosengrenLund University Diabetes Center, CRC 91-11 SUS, Jan Waldenströms gata 35, SE-20502 Malmö, Sweden.
Lund University · SESage Bionetworks · USRWTH Aachen University · DEUniversity of British Columbia · CAHawler Medical University · IQOFM Research (United States) · USUniversity of California, Los Angeles · USUniversity of Geneva · CH

Funding

DHA Reverses Gene Network Signatures of Fructose-induced Metabolic SyndromeR01DK104363 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, XIA · 2015 to 2019
$2.4M
NIDDK NIH HHS R01 DK104363
6 · The paper itself

Abstract

Type 2 diabetes (T2D) is characterized by insulin resistance and impaired insulin secretion, but the mechanisms underlying insulin secretion failure are not completely understood. Here, we show that a set of co-expressed genes, which is enriched for genes with islet-selective open chromatin, is associated with T2D. These genes are perturbed in T2D and have a similar expression pattern to that of dedifferentiated islets. We identify Sox5 as a regulator of the module. Sox5 knockdown induces gene expression changes similar to those observed in T2D and diabetic animals and has profound effects on insulin secretion, including reduced depolarization-evoked Ca

Indexed as

AnimalsCalciumCalcium ChannelsChromatinDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2ExocytosisFemaleGene Expression RegulationHumansInsulinInsulin-Secreting CellsIslets of LangerhansMaleMiceMice, Inbred C57BLCalciumCalcium ChannelsChromatinInsulinPhlorhizinRNA, Small InterferingSOX5 protein, humanSox5 protein, mouseSOXD Transcription FactorsValproic Acid

Identifiers

PMID28585545
PMCPMC5467166
OpenAlexW2622402732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.